Vapotherm HVT 2.0
Hi-VNI Technology achieves CO₂ clearance through velocity-driven dead-space washout – ventilatory support without a mask, independent of positive pressure
Patients with hypercapnic or hypoxemic respiratory failure who cannot tolerate mask-based NIV face a narrow window between conservative oxygen therapy and intubation. HVT 2.0 delivers Hi-VNI Technology via small-bore nasal cannula, flushing nasopharyngeal dead space in 2.2 seconds per breath and providing 100% relative humidity — with prospective evidence of efficacy comparable to NiPPV for intubation rates in adults with acute respiratory distress.
- CO₂ clearance via dead-space washout – Nasopharyngeal washout in 2.2 seconds per breath cycle, independent of applied pressure
- Clinically validated NIV alternative -Efficacy comparable to NiPPV without the mask interface
- Enhanced oxygenation -Vapor transfer membrane delivers 100% relative humidity, maintaining mucosal integrity
- Zero cross-contamination risk -Closed single-use patient circuit; no disinfection protocol required.
- Mask-free continuous therapy -Oral intake, communication, and nebulization without interruption.
- Single-use patient circuit – no device downtime between patients.
- Operational within 2 minutes – no circuit assembly, no mask fitting, no calibration.
- 90-minute battery runtime supports intra-hospital transport and ambulation.
- One disposable set across adult, pediatric, and neonatal patients.
- No wall-air dependency – internal blower enables deployment anywhere.
Used in patients with hypercapnic or hypoxemic respiratory failure requiring non-invasive support. High Velocity Therapy enables mask-free NIV while delivering heated gas at 100% relative humidity.
